IV anti-virus patents lack an ‘inventive concept’, US court rules
A US court has said that two patents previously asserted by licensing company Intellectual Ventures (IV) against four anti-virus businesses do not cover patent-eligible subject matter.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
9 February 2015 A US court has awarded licensing company Intellectual Ventures $17 million in damages after finding that anti-virus software business Symantec infringed two of its patents.
4 October 2016 Software patents impose a “deadweight loss on the nation’s economy”, according to a judge at the US Court of Appeals for the Federal Circuit.